Ancestry® Expands Reference Panel to Deliver More Precise Results and New Regions

Consumer genomics is a new and evolving field and Ancestry® is at the forefront, constantly developing new ways for you to learn about yourself through DNA. Today, we’re proud to announce that our team of scientists have increased the AncestryDNA® reference panel to more than double its previous size with samples from more places around the world, resulting in the latest update to AncestryDNA ethnicity estimates.

Over the next several months, AncestryDNA customers may receive updated ethnicity estimates, thanks to our expanded reference panel, which allows us to determine ethnic breakdowns with a higher degree of precision. This means there may be some changes to your results.
Additional story at: https://tinyurl.com/y2lu9ybr

Ancestry's DNA health screening will require doctor's order

Ancestry.com is entering the growing field of genetic health screenings with a strategy that’s markedly different from that of its biggest competitor.

Ancestry said Tuesday that its new consumer health tests will require authorization by a physician. Its main competitor, 23andMe, went through the lengthy and expensive process of getting approval from the Food and Drug Administration so it can sell its tests directly to customers without a prescription.

The involvement of doctors in Ancestry’s tests places it in the midst of a debate over whether physician-ordered genetic screening is merely a way for companies to avoid the regulatory scrutiny of the FDA. Several other DNA startups, including Color and Veritas, also require a doctor to order health tests.

Additional story at Health Watch: https://www.healthdatamanagement.com/articles/ancestrys-dna-health-screening-will-require-doctors-order